BioGaia AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0017769995
SEK
117.00
4.6 (4.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
440.57
326.64
404.69
366.26
364.83
303.97
384.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
440.57
326.64
404.69
366.26
364.83
303.97
384.12
Raw Material Cost
116.74
84.13
110.81
97.90
106.29
81.64
100.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.23
3.59
2.52
2.10
9.61
2.29
1.48
Selling and Distribution Expenses
159.68
126.67
150.35
124.19
133.57
104.77
116.03
Other Expenses
3.66
2.23
2.79
2.06
2.42
6.91
2.53
Total Expenditure (Excl Depreciation)
313.21
236.68
291.55
244.76
273.63
257.79
242.94
Operating Profit (PBDIT) excl Other Income
127.4
90
113.10000000000001
121.5
91.19999999999999
46.2
141.2
Other Income
-3.55
-1.05
-0.21
-17.49
22.90
3.10
3.05
Operating Profit (PBDIT)
129.94
95.05
119.12
110.22
121.35
106.82
150.38
Interest
0.23
3.59
2.52
2.10
9.61
2.29
1.48
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
323.83
242.50
293.88
268.36
258.54
222.34
284.04
Depreciation
6.13
6.14
6.20
6.20
7.26
57.55
6.15
Profit Before Tax
123.58
85.32
110.40
101.91
104.49
46.98
142.75
Tax
24.80
19.44
22.50
21.71
22.56
10.38
31.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
98.78
65.88
87.91
80.20
81.93
36.60
111.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
98.78
65.88
87.91
80.20
81.93
36.60
111.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
98.78
65.88
87.91
80.20
81.93
36.60
111.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
1,314.22
1,218.02
1,154.71
1,779.08
1,723.93
1,619.80
1,575.31
Earnings per share (EPS)
0.98
0.65
0.87
0.79
0.81
0.36
1.1
Diluted Earnings per share
0.98
0.65
0.87
0.79
0.81
0.36
1.1
Operating Profit Margin (Excl OI)
28.91%
27.54%
27.96%
33.17%
25.0%
15.19%
36.75%
Gross Profit Margin
29.44%
28.0%
28.81%
29.52%
30.63%
34.39%
38.76%
PAT Margin
22.42%
20.17%
21.72%
21.9%
22.46%
12.04%
28.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 34.91% vs -19.30% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 49.92% vs -25.03% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 38.92% vs -19.45% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -94.44% vs 44.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of BioGaia AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
440.57
933.00
-492.43
-52.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
440.57
933.00
-492.43
-52.78%
Raw Material Cost
116.74
666.00
-549.26
-82.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.23
8.00
-7.77
-97.12%
Selling and Distribution Expenses
159.68
219.00
-59.32
-27.09%
Other Expenses
3.66
-0.80
4.46
557.50%
Total Expenditure (Excl Depreciation)
313.21
885.00
-571.79
-64.61%
Operating Profit (PBDIT) excl Other Income
127.36
48.00
79.36
165.33%
Other Income
-3.55
-1.00
-2.55
-255.00%
Operating Profit (PBDIT)
129.94
81.00
48.94
60.42%
Interest
0.23
8.00
-7.77
-97.12%
Exceptional Items
0.00
-5.00
5.00
100.00%
Gross Profit (PBDT)
323.83
267.00
56.83
21.28%
Depreciation
6.13
34.00
-27.87
-81.97%
Profit Before Tax
123.58
33.00
90.58
274.48%
Tax
24.80
0.00
24.80
Provisions and contingencies
0
0
0.00
Profit After Tax
98.78
33.00
65.78
199.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
98.78
33.00
65.78
199.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
98.78
33.00
65.78
199.33%
Equity Capital
0
0
0.00
Face Value
0.00
5.00
0.00
Reserves
1,314.22
2,933.00
-1,618.78
-55.19%
Earnings per share (EPS)
0.98
0.23
0.75
326.09%
Diluted Earnings per share
0.98
0.23
0.75
326.09%
Operating Profit Margin (Excl OI)
28.91%
5.14%
0.00
23.77%
Gross Profit Margin
29.44%
7.18%
0.00
22.26%
PAT Margin
22.42%
3.54%
0.00
18.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 44.06 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 34.91% vs -19.30% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 20.78% vs 22.50% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.88 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 49.92% vs -25.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 20.63% vs 21.51% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.35 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 38.92% vs -19.45% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 35.53% vs 2.39% in Dec 2024

Quarterly - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -94.44% vs 44.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -97.92% vs -27.27% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.91%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024